Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fibrosis × Everolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 92 Carcinoma, Renal Cell 65 Neoplasm Metastasis 41 Neoplasms 34 Neuroendocrine Tumors 31 Kidney Neoplasms 24 Recurrence 16 Prostatic Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Tuberous Sclerosis 14 Triple Negative Breast Neoplasms 13 Head and Neck Neoplasms 13 Lymphoma, Mantle-Cell 12 Lymphoma 12 Glioblastoma 12 Carcinoma, Hepatocellular 12 Pancreatic Neoplasms 11 Lymphoma, Large B-Cell, Diffuse 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Hodgkin Disease 11 Colorectal Neoplasms 11 Brain Neoplasms 11 Sarcoma 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Carcinoma, Neuroendocrine 10 Waldenstrom Macroglobulinemia 9 Lymphoma, Follicular 9 Lung Neoplasms 9 Glioma 9 Stomach Neoplasms 8

Interventions

Blood Specimen Collection 8 Magnetic Resonance Spectroscopy 5 Pentoxifylline 4 Liver Transplantation 4 Tenofovir 3 Specimen Handling 3 High-Energy Shock Waves 3 Tocopherols 2 Sorafenib 2 Simvastatin 2 Low-Level Light Therapy 2 Gemcitabine 2 tremelimumab 1 sonidegib 1 sofosbuvir-velpatasvir drug combination 1 ruxolitinib 1 peginterferon alfa-2a 1 navitoclax 1 maltodextrin 1 hepatitis B hyperimmune globulin 1 esmolol 1 epigallocatechin gallate 1 durvalumab 1 contrast agent BR1 1 bavituximab 1 atezolizumab 1 apixaban 1 alpha-Tocopherol 1 adefovir dipivoxil 1 Viusid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02134899 2018-12-10

EVERKYSTE

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Cysts, Fibrosis, Polycystic Kidney, Autosomal Dominant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡